S. -c. Huang
#161,660
Most Influential Person Now
S. -c. Huang's AcademicInfluence.com Rankings
S. -c. Huangengineering Degrees
Engineering
#6989
World Rank
#8347
Historical Rank
Biomedical Engineering
#665
World Rank
#677
Historical Rank
S. -c. Huangphilosophy Degrees
Philosophy
#9344
World Rank
#12887
Historical Rank
Logic
#6324
World Rank
#7833
Historical Rank
Download Badge
Engineering Philosophy
Why Is S. -c. Huang Influential?
(Suggest an Edit or Addition)S. -c. Huang's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method (1979) (1786)
- Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size (1979) (1241)
- TOMOGRAPHIC MEASUREMENT OF LOCAL CEREBRAL GLUCOSE METABOLIC RATE IN HUMANS WITH (F‐18)2‐FLUORO-2‐DEOXY-D‐GLUCOSE: VALIDATION OF METHOD (1980) (1197)
- Noninvasive determination of local cerebral metabolic rate of glucose in man. (1980) (1034)
- Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. (2000) (734)
- Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. (2001) (562)
- Quantifying local cerebral blood flow by N-isopropyl-p-[123I]iodoamphetamine (IMP) tomography. (1982) (494)
- Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia (1983) (447)
- Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET. (1992) (377)
- Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. (1995) (359)
- Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. (1987) (334)
- Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. (1989) (296)
- ECAT: a new computerized tomographic imaging system for positron-emitting radiopharmaceuticals. (1978) (291)
- 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. (1989) (275)
- Quantitation in positron emission computed tomography: 2. Effects of inaccurate attenuation correction. (1979) (274)
- Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin. (1979) (274)
- Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. (1982) (274)
- Dissociation of cerebral glucose metabolism and level of consciousness during the period of metabolic depression following human traumatic brain injury. (2000) (269)
- Investigation of [18F]2-fluoro-2-deoxyglucose for the measure of myocardial glucose metabolism. (1978) (246)
- Regional myocardial perfusion assessed with N-13 labeled ammonia and positron emission computerized axial tomography. (1979) (239)
- Quantitation in Positron Emission Computed Tomography: 4. Effect of Accidental Coincidences (1981) (231)
- Models for computer simulation studies of input functions for tracer kinetic modeling with positron emission tomography. (1993) (220)
- C- 11 labeled palmitic acid for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. I. Kinetics of C- 11 palmitic acid in normal myocardium. (1982) (198)
- Anatomy of SUV. Standardized uptake value. (2000) (191)
- Kinetics and Modeling of l-6-[18F]Fluoro-DOPA in Human Positron Emission Tomographic Studies (1991) (177)
- Validation of PET-acquired input functions for cardiac studies. (1988) (175)
- Noninvasive quantification of myocardial blood flow in humans. A direct comparison of the [13N]ammonia and the [15O]water techniques. (1996) (160)
- Effect of positron range on spatial resolution. (1975) (147)
- Measurements of regional tissue and blood-pool radiotracer concentrations from serial tomographic images of the heart. (1983) (145)
- Factor analysis for extraction of blood time-activity curves in dynamic FDG-PET studies. (1995) (134)
- Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2-deoxy-d-glucose studies. (1991) (131)
- C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron computed tomography. III. In vivo demonstration of the effects of substrate availability on myocardial metabolism. (1983) (130)
- Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. (1998) (124)
- Measurement of regional myocardial blood flow with N-13 ammonia and positron-emission tomography in intact dogs. (1985) (122)
- A BOUNDARY METHOD FOR ATTENUATION CORRECTION IN POSITRON COMPUTED TOMOGRAPHY (1981) (121)
- Whole body skeletal imaging with [18F]fluoride ion and PET. (1993) (118)
- Quantitation in Positron Emission Computed Tomography: 6. Effect of Nonuniform Resolution (1982) (117)
- A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. (1993) (113)
- Retention and clearance of C-11 palmitic acid in ischemic and reperfused canine myocardium. (1985) (111)
- Performance evaluation of a positron tomograph designed for brain imaging. (1983) (100)
- Use of the abdominal aorta for arterial input function determination in hepatic and renal PET studies. (1992) (100)
- The effects of measurement errors in the plasma radioactivity curve on parameter estimation in positron emission tomography. (1991) (94)
- Quantitating tumor glucose metabolism with FDG and PET. (1992) (92)
- C-11 palmitate for the noninvasive evaluation of regional myocardial fatty acid metabolism with positron-computed tomography. IV. In vivo evaluation of acute demand-induced ischemia in dogs. (1983) (92)
- Fluorodeoxyglucose rate constants, lumped constant, and glucose metabolic rate in rabbit heart. (1987) (91)
- An analysis of signal amplification using small detectors in positron emission tomography. (1982) (91)
- Intracarotid infusion of RMP-7, a bradykinin analog, and transport of gallium-68 ethylenediamine tetraacetic acid into human gliomas. (1997) (90)
- Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. (1999) (90)
- Cerebral Extraction of N‐13 Ammonia: Its Dependence on Cerebral Blood Flow and Capillary Permeability — Surface Area Product (1981) (88)
- Effects of substrate availability on myocardial C-11 palmitate kinetics by positron emission tomography in normal subjects and patients with ventricular dysfunction. (1986) (85)
- Quantitation in Positron Emission Computed Tomography: 3. Effect of Sampling (1980) (84)
- The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography. (1992) (82)
- Estimation of rabbit myocardial metabolic rate for glucose using fluorodeoxyglucose. (1982) (79)
- Quantitative measurement of myocardial blood flow with oxygen-15 water and positron computed tomography: an assessment of potential and problems. (1985) (73)
- Evaluation of the effect of glucose ingestion and kinetic model configurations of FDG in the normal liver. (1994) (73)
- Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. (1993) (72)
- Regional myocardial blood flow, metabolism and function assessed noninvasively with positron emission tomography. (1980) (68)
- Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. (2009) (67)
- L-6-[18F]Fluoro-DOPA Metabolism in Monkeys and Humans: Biochemical Parameters for the Formulation of Tracer Kinetic Models with Positron Emission Tomography (1991) (66)
- 6‐[18F]Fluoro‐L‐DOPA probes dopamine turnover rates in central dopaminergic structures (1990) (64)
- Rabbit myocardial 82Rb kinetics and a compartmental model for blood flow estimation. (1989) (61)
- Quantification of myocardial blood flow using dynamic nitrogen-13-ammonia PET studies and factor analysis of dynamic structures. (1995) (60)
- Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome. (2011) (60)
- 4‐[18F]Fluoro‐L‐m‐Tyrosine: An L‐3,4‐Dihydroxyphenylalanine Analog for Probing Presynaptic Dopaminergic Function with Positron Emission Tomography (1989) (60)
- Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. (1991) (58)
- Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease (2007) (58)
- Derivation of input function from FDG-PET studies in small hearts. (1996) (57)
- Quantification and parametric imaging of renal cortical blood flow in vivo based on Patlak graphical analysis. (1993) (55)
- Issues in the quantitation of reoriented cardiac PET images. (1992) (53)
- An investigation of a double-tracer technique for positron computerized tomography. (1982) (53)
- Biological imaging and the molecular basis of dopaminergic diseases. (1997) (52)
- Dependence of 13NH3 myocardial extraction and clearance on flow and metabolism. (1982) (50)
- Validation of a model for [1-11C]acetate as a tracer of cardiac oxidative metabolism. (1994) (49)
- A quantitative index of regional blood flow in canine myocardium derived noninvasively with N-13 ammonia and dynamic positron emission tomography. (1991) (46)
- A modeling method to improve quantitation of fluorodeoxyglucose uptake in heterogeneous tumor tissue. (1995) (46)
- 3-(2'-[18F]fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans. (1990) (45)
- A theoretical study of quantitative flow measurements with constant infusion of short-lived isotopes. (1979) (44)
- Quantitation in Positron Emission Tomography: 8. Effects of Nonlinear Parameter Estimation on Functional Images (1987) (41)
- Relationship between Tl-201, Tc-99m (Sn) pyrophosphate and F-18 2-deoxyglucose uptake in ischemically injured dog myocardium. (1987) (41)
- Correction of spillover radioactivities for estimation of the blood time-activity curve from the imaged LV chamber in cardiac dynamic FDG PET studies. (1995) (41)
- Assessment of the [18F]fluorodeoxyglucose kinetic model in calculations of myocardial glucose metabolism during ischemia. (1983) (40)
- Estrogen use and brain metabolic change in older adults. A preliminary report (2001) (40)
- Modelling approach for separating blood time-activity curves in positron emission tomographic studies. (1991) (39)
- No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography. (1986) (39)
- Tracer kinetic modeling approaches for the quantification of hepatic function with technetium-99m DISIDA and scintigraphy. (1989) (39)
- Amyloid and tau imaging, neuronal losses and function in mild cognitive impairment (2008) (38)
- A new noninvasive quantification of renal blood flow with N-13 ammonia, dynamic positron emission tomography, and a two-compartment model. (1992) (38)
- A New Tomograph for Quantitative Positron Emission Computed Tomography of the Brain (1981) (38)
- Compartment model for measuring myocardial oxygen consumption using [1-11C]acetate. (1997) (37)
- Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA. (2001) (35)
- Radionuclide evaluation of liver transplants. (1988) (33)
- Automated image registration for FDOPA PET studies. (1996) (31)
- FLT-PET Imaging of Radiation Responses in Murine Tumors (2008) (30)
- Effect of exercise supplementation during adenosine infusion on hyperemic blood flow and flow reserve. (1994) (28)
- Investigation of a Technique for Providing a Pseudo-Continuous Detector Ring for Positron Tomography (1982) (27)
- In vivo assessment of neurotransmitter biochemistry in humans. (1988) (23)
- A new double modeling approach for dynamic cardiac PET studies using noise and spillover contaminated LV measurements. (1996) (23)
- Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia (2012) (23)
- Estimation of myocardial glucose utilisation with PET using the left ventricular time-activity curve as a non-invasive input function (2006) (21)
- Noninvasive quantification of hepatic arterial blood flow with nitrogen-13-ammonia and dynamic positron emission tomography. (1991) (21)
- Methods for improving quantitation of putamen uptake constant of FDOPA in PET studies. (1993) (20)
- Evaluating the Performance of Multiplane Positron Tomographs Designed for Brain Imaging (1982) (20)
- New estimation methods that directly use the time accumulated counts in the input function in quantitative dynamic PET studies. (1994) (20)
- PET investigation of post-traumatic cerebral blood volume and blood flow. (2003) (19)
- A refined method for quantification of myocardial oxygen consumption rate using mean transit time with carbon-11-acetate and dynamic PET. (1993) (18)
- Quantification of serial tumor glucose metabolism. (1996) (16)
- Positron tomography: "in vivo" autoradiographic approach to measurement of cerebral hemodynamics and metabolism. (1977) (15)
- The assessment of the non-equilibrium effect in the 'Patlak analysis' of Fdopa PET studies. (1995) (12)
- 2Beta-carbomethoxy-3beta-(4- and 2-[18F]fluoromethylphenyl)tropanes: specific probes for in vivo quantification of central dopamine transporter sites. (1999) (12)
- Positron tomography of the heart. (1980) (10)
- F-18 fluoride PET : is non-invasive quantitation feasible with factor analysis ? (1997) (10)
- Dynamic positron tomographic imaging with nitrogen-13 glutamate in patients with coronary artery disease: comparison with nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose imaging. (1990) (10)
- [18F]Fluoro-beta-fluoromethylene-m-tyrosine derivatives show stereo, geometrical, and regio specificities as in vivo central dopaminergic probes in monkeys. (1999) (7)
- Noninvasive detection of functionally significant coronary artery stenoses with exercise and positron emission tomography. (1991) (7)
- Positron Emission Tomography of Brain (cid:2) -Amyloid and Tau Levels in Adults With Down Syndrome (2011) (6)
- An evaluation of Bayesian regression for estimating cerebral oxygen utilization with oxygen-15 and dynamic PET. (1988) (6)
- Quality control in PET systems employing 2-D modular detectors (1989) (5)
- P2-274 FDDNP-PET binding differentiates MCI from dementia and increases with clinical progression (2006) (5)
- Error in parameter estimates with variations in flow: measurement of oxygen utilization with positron-emission tomography. (1985) (5)
- Correlation of myocardial necrosis with kinetics of 111In-labeled myosin-specific antibody in isolated rabbit septum. (1991) (4)
- Simultaneous estimations of blood brain barrier (BBB) permeability and local cerebral blood volume (CBV) in human brain tumors with positron tomography and Ga-68 EDTA (1984) (4)
- FDDNP-PET Scanning of Cerebral Amyloid and Tau Deposits in MCI (2006) (4)
- Dependence of /sup 13/NH/sub 3/ myocardial extraction and clearance on flow and metabolism. [Rabbits] (1982) (4)
- Improved Estimation of Local Cerebral Glucose Metabolic Rate Using Bayes Regression Analysis of PET Scan Data. (1984) (3)
- A New Method of Selectively Analyzing Gray-or White-Matter Uptake in Brain PET Images (2002) (3)
- Factors affecting estimation of the rate constants of the fluorodeoxyglucose (FDG) model from positron emission tomography (PET) data (1984) (3)
- Influence of APOE genotype and pet brain imaging on preclinical prediction of Alzheimer disease (2000) (2)
- Influence of iterative reconstruction on parameter estimation with three-compartment kinetic modeling (1997) (2)
- CORTICAL BRAIN SURFACE MAPPING FOR STUDYING PARTIAL VOLUME EFFECTS IN BRAIN FDG PET IMAGES (2005) (2)
- O2-02-05 FDDNP-PET binding values from cortical hemispheric surface maps correlate with MMSE scores (2007) (2)
- Error analysis of the integrated projection technique (IP) and the weighted integration method (WI) for measurement of local cerebral blood flow (LCBF) with positron emission tomography (PET) (1984) (2)
- Preoperative determination of reversibility of wall motion abnormalities using F-18 fluorodeoxyglucose and N-13 ammonia positron tomography (1984) (2)
- Effects of inhibition of. beta. -oxidation on tissue kinetics of C-11 palmitate in normal myocardium (1985) (1)
- O3-06-06 [18F]FDDNP-PET imaging in persons at-risk for familial AD (2006) (1)
- Practical procedures and pharmacological applications of quantitative PET. (1993) (1)
- In vivo kinetics of (H-3)spiperone in rat brain (1984) (1)
- Signal Amplification Technique (SAT): an approach for improving resolution and reducing image noise in computed tomography (1981) (1)
- Cerebral protein synthesis rates in vivo: Estimation via biochemical analyses and tracer kinetic modeling (1985) (1)
- Synthesis of 3beta-(4-[18F]fluoromethylphenyl)- and 3beta-(2-[18F] fluoromethylphenyl)tropane-2beta-carboxylic acid methyl esters: new ligands for mapping brain dopamine transporter with positron emission tomography. (1999) (0)
- IC-P3-218: Long-term effects of donepezil versus placebo on regional brain metabolism in minimally impaired subjects (2008) (0)
- Measurement of regional cerebral metabolic rate for glucose in the human subject with (F-18)-2-deoxy-2-fluoro-d-glucose and emission computed tomography: validation of the method (1977) (0)
- Effect of model configuration on CMRO/sub 2/ measurements by dynamic PET and O-15 oxygen (1985) (0)
- A correlative study of clinical-pathologic characteristics of human brain tumors and blood brain barrier (BBB) permeability evaluated with Ga-68 EDTA and positron emission tomography (1985) (0)
- The 5-parameter FDG model: Sampling requirements and validation studies (1985) (0)
- Emission computed tomography: a new technique for the quantitative physiologic study of brain and heart in vivo (1978) (0)
- An Investigationof a Double†” TracerT chniquefor PositronComputerized Tomography (2006) (0)
- A new method for quantitating total lesion glucose metabolic changes in serial tumor FDG PET studies (1994) (0)
- Investlg atlon of [ ‘8 F] 2- Fluoro-2--Deoxyglu cose for the Measure of Myocardlal Glucose Metabolism (2006) (0)
- Cerebral metabolic rate of glucose computed by Bayes regression of deoxyglucose PET scans (1984) (0)
- Reproducibility study of a non-invasive positron CT (PCT) technique using O-15 water for screening relative cerebral blood flow responses due to neurobehavior interventions (1984) (0)
- Assessment of myocardial injury after reperfusion with T1-201, Tc-99m pyrophosphate (PPi) and F-18 deoxyglucose (FDG) (1984) (0)
- A study of the FDG model in the presence of an altered blood brain barrier (BBB) and glucose metabolic/flow relationships in human brain tumors with PET (1985) (0)
- Visual system involvement in Alzheimer’s disease (2019) (0)
- An Investigation of a Doubleâ€"Tracer Technique for PositronComputerized Tomography (1982) (0)
- IC-103-02 Cerebral FDDNP-PET binding increases in MCI and aging as neurodegeneration progresses (2006) (0)
- A method for simultaneous determination of (I) the blood flows to the organs and (II) the cardiac output. (1973) (0)
- An Investigationof a Double—TracerTechniquefor PositronComputerized Tomography (2006) (0)
- ValIdation of Tomographlc Measurement of Cerebral Blood Volume with C-il-Labeled Carboxyhemoglobin (2006) (0)
- QuantitativeMeasurementof Myocardial Blood Flow with Oxygen-15 Water and Positron Computed Tomography:An Assessment of Potential and Problems (2006) (0)
This paper list is powered by the following services:
